Variant report
Variant | nsv817741 |
---|---|
Chromosome Location | chr16:77202701-77211339 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:16)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:16 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:77206067..77208430-chr16:77215088..77217473,2 | MCF-7 | breast: | |
2 | chr16:76887924..76888465-chr16:77203271..77204023,2 | MCF-7 | breast: | |
3 | chr16:75822777..75823699-chr16:77203448..77204260,4 | K562 | blood: | |
4 | chr16:76313028..76313530-chr16:77203611..77204279,2 | MCF-7 | breast: | |
5 | chr16:76699516..76700310-chr16:77203606..77204151,2 | MCF-7 | breast: | |
6 | chr16:75497933..75499469-chr16:77204517..77206368,2 | MCF-7 | breast: | |
7 | chr16:76699506..76700441-chr16:77205329..77206242,3 | MCF-7 | breast: | |
8 | chr16:75822932..75823933-chr16:77203258..77204234,7 | MCF-7 | breast: | |
9 | chr16:77078662..77079429-chr16:77203303..77204211,3 | MCF-7 | breast: | |
10 | chr16:76887394..76888672-chr16:77203188..77204165,5 | MCF-7 | breast: | |
11 | chr16:76887878..76888800-chr16:77205307..77205910,4 | MCF-7 | breast: | |
12 | chr16:77076688..77077729-chr16:77203577..77204202,3 | MCF-7 | breast: | |
13 | chr16:75822791..75823761-chr16:77205366..77206287,6 | MCF-7 | breast: | |
14 | chr16:76312786..76313346-chr16:77205382..77206025,2 | MCF-7 | breast: | |
15 | chr16:75835360..75835894-chr16:77203310..77204256,2 | K562 | blood: | |
16 | chr16:75823072..75823718-chr16:77205249..77205759,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000261717 | chromatin interactions |
ENSG00000166822 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs8046951 | chr16:77202701-77202702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs138930952 | chr16:77202711-77202712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs191513562 | chr16:77202726-77202727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs553306823 | chr16:77202727-77202728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs529176542 | chr16:77202738-77202739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs57406449 | chr16:77202751-77202752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549295084 | chr16:77202794-77202795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562103767 | chr16:77202813-77202814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs182134805 | chr16:77202819-77202820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547939565 | chr16:77202827-77202828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs375447584 | chr16:77202844-77202845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs533425269 | chr16:77202856-77202857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs566367261 | chr16:77202867-77202868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573199044 | chr16:77202877-77202878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs550112255 | chr16:77202878-77202879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs8047326 | chr16:77202880-77202881 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs143296104 | chr16:77202901-77202902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs1834050 | chr16:77202937-77202938 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs562373716 | chr16:77202953-77202954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs1834049 | chr16:77202959-77202960 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs368040596 | chr16:77202965-77202966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1834048 | chr16:77202966-77202967 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs34897292 | chr16:77202990-77202991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577671259 | chr16:77203056-77203057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs543455793 | chr16:77203062-77203063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs1834047 | chr16:77203068-77203069 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs147519807 | chr16:77203106-77203107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186723894 | chr16:77203120-77203121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs140074769 | chr16:77203121-77203122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs76169029 | chr16:77203156-77203157 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs191864967 | chr16:77203189-77203190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs35738564 | chr16:77203191-77203192 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs201942585 | chr16:77203233-77203234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs184865836 | chr16:77203256-77203257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs34820071 | chr16:77203281-77203282 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs190032538 | chr16:77203294-77203295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs142778005 | chr16:77203301-77203302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs549140536 | chr16:77203313-77203314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs12599305 | chr16:77203323-77203324 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs534943306 | chr16:77203362-77203363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs193022385 | chr16:77203366-77203367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs371894329 | chr16:77203425-77203426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs571217624 | chr16:77203466-77203467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs374964254 | chr16:77203492-77203493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs536785836 | chr16:77203526-77203527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs144470558 | chr16:77203555-77203556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs386792339 | chr16:77203585-77203586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs74027155 | chr16:77203586-77203587 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs111728784 | chr16:77203587-77203588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs528866798 | chr16:77203607-77203608 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 19156837 | CNVD |
Acute myeloid leukemia | 17377590 | CNVD |
Breast cancer | 20409316 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Lung cancer | 24585490 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20581869 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Melanoma | 17363583 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:77200200-77203200 | Weak transcription | Fetal Muscle Leg | muscle |
2 | chr16:77203200-77203600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
3 | chr16:77203200-77203800 | Enhancers | Fetal Muscle Leg | muscle |
4 | chr16:77203600-77204800 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
5 | chr16:77203800-77204400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr16:77203800-77204400 | Weak transcription | Fetal Muscle Leg | muscle |
7 | chr16:77204400-77205000 | Enhancers | Fetal Muscle Leg | muscle |
8 | chr16:77204400-77206000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr16:77204600-77205000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
10 | chr16:77204600-77205800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr16:77204800-77205400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
12 | chr16:77205800-77206200 | Flanking Active TSS | HUVEC | blood vessel |
13 | chr16:77206000-77206600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
14 | chr16:77206000-77207600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr16:77206200-77207800 | Enhancers | HUVEC | blood vessel |
16 | chr16:77206800-77207200 | Enhancers | Cortex derived primary cultured neurospheres | brain |